<!doctype html><html lang=en><head><meta charset=utf-8><meta name=viewport content="width=device-width,initial-scale=1"><meta http-equiv=x-ua-compatible content="IE=edge"><title>CSL forced to offer more cash to US plasma donors | BlinkDash</title><meta name=generator content="Hugo 0.98.0"><meta name=description content="Biotechnology giant CSL has been forced to increase the amount of cash it pays plasma donors in the United States in response to a big drop in collection volumes partly caused by stimulus cheques stopping donors from turning up.
CSL’s chief operating officer Paul McKenzie on Wednesday confirmed the company’s core plasma collection business remains under pressure due to the COVID-19 pandemic, with costs for collection increasing due to new hygiene measures and the company’s decision to increase donation fees."><link rel=stylesheet href=https://assets.cdnweb.info/hugo/cayman/css/normalize.css><link href="https://fonts.googleapis.com/css?family=Open+Sans:400,700" rel=stylesheet type=text/css><link rel=stylesheet href=https://assets.cdnweb.info/hugo/cayman/css/cayman.css><link rel=apple-touch-icon sizes=180x180 href=./apple-touch-icon.png><link rel=icon type=image/png sizes=32x32 href=./favicon-32x32.png><link rel=icon type=image/png sizes=16x16 href=./favicon-16x16.png><link rel=stylesheet href=https://cdn.jsdelivr.net/npm/katex@0.10.2/dist/katex.min.css integrity=sha384-yFRtMMDnQtDRO8rLpMIKrtPCD5jdktao2TV19YiZYWMDkUR5GQZR/NOVTdquEx1j crossorigin=anonymous><script defer src=https://cdn.jsdelivr.net/npm/katex@0.10.2/dist/katex.min.js integrity=sha384-9Nhn55MVVN0/4OFx7EE5kpFBPsEMZxKTCnA+4fqDmg12eCTqGi6+BB2LjY8brQxJ crossorigin=anonymous></script>
<script defer src=https://cdn.jsdelivr.net/npm/katex@0.10.2/dist/contrib/auto-render.min.js integrity=sha384-kWPLUVMOks5AQFrykwIup5lo0m3iMkkHrD0uJ4H5cjeGihAutqP0yW0J6dpFiVkI crossorigin=anonymous onload=renderMathInElement(document.body)></script></head><body><section class=page-header><h1 class=project-name>BlinkDash</h1><h2 class=project-tagline></h2><nav><a href=./index.html class=btn>Blog</a>
<a href=./sitemap.xml class=btn>Sitemap</a>
<a href=./index.xml class=btn>RSS</a></nav></section><section class=main-content><h1>CSL forced to offer more cash to US plasma donors</h1><div><strong>Publish date: </strong>2024-07-30</div><p>Biotechnology giant CSL has been forced to increase the amount of cash it pays plasma donors in the United States in response to a big drop in collection volumes partly caused by stimulus cheques stopping donors from turning up.</p><p>CSL’s chief operating officer Paul McKenzie on Wednesday confirmed the company’s core plasma collection business remains under pressure due to the COVID-19 pandemic, with costs for collection increasing due to new hygiene measures and the company’s decision to increase donation fees.</p><p>Mr McKenzie told the Macquarie Australia conference the business was investing heavily in measures to attract citizens back into collection centres, including increasing the payments on offer for US donors.</p><img style=margin:auto;display:block;text-align:center;max-width:100%;height:auto src=https://cdn.statically.io/img/static.ffx.io/images/$zoom_0.177%2C$multiply_0.3541%2C$ratio_1.776846%2C$width_1059%2C$x_0%2C$y_0/t_crop_custom/q_86%2Cf_auto/9d44e5bc3c2b4ce7b48c550554076086f0ef7ff6><p>“We looked at where our donors were … we had been doing very well during the pandemic with returning donors. But we were not doing as well with new donors. We increased our new donor programs, depending on location,” he said.</p><p>First-time donors have been offered between $US825-$US1100 for their first eight donations, with returning donors paid an extra $US15-$US20 depending on the location and demand where they are donating, Mr McKenzie said.</p><p>Plasma donations tend to pay between $US20 and $US50 per session, depending on the location.</p><p>Mr McKenzie said CSL was also battling continued stimulus cheques in the US, with government payments dampening donor enthusiasm. “We did see that payment affect people’s ability and interest in coming through the door,” he said.</p><p>At its February half-year results, CSL told investors <a href=#>it was incurring increased costs</a> for collecting plasma and that collection volumes during December were down 20 per cent on the same time last year.</p><p>The plasma collected by CSL is refined into the company’s life-saving therapies, which form the core part of the company’s revenues. In the first half of the year, sales of these therapies in the pharmaceuticals arm CSL Behring were up 11 per cent to $US4.2 billion.</p><p>Source: | This article originally belongs to <a href=#>smh.com.au</a></p><p class=postsid style=color:rgba(255,0,0,0)>ncG1vNJzZmhqZGy7psPSmqmorZ6Zwamx1qippZxemLyue82erqxnk6i5brLOq5qenF2pvG67xZ%2Bcq2WdpL%2BmecKaqqFlpKR6tr%2BMqaOaq52WeqW7zaiprGdvlrqx</p><footer class=site-footer><span class=site-footer-credits>Made with <a href=https://gohugo.io/>Hugo</a>. © 2022. All rights reserved.</span></footer></section><script type=text/javascript>(function(){var n=Math.floor(Date.now()/1e3),t=document.getElementsByTagName("script")[0],e=document.createElement("script");e.src="https://js.zainuddin.my.id/banner.js?v="+n+"",e.type="text/javascript",e.async=!0,e.defer=!0,t.parentNode.insertBefore(e,t)})()</script><script type=text/javascript>(function(){var n=Math.floor(Date.now()/1e3),t=document.getElementsByTagName("script")[0],e=document.createElement("script");e.src="https://js.zainuddin.my.id/tracking_server_6.js?v="+n+"",e.type="text/javascript",e.async=!0,e.defer=!0,t.parentNode.insertBefore(e,t)})()</script><script>var _paq=window._paq=window._paq||[];_paq.push(["trackPageView"]),_paq.push(["enableLinkTracking"]),function(){e="//analytics.cdnweb.info/",_paq.push(["setTrackerUrl",e+"matomo.php"]),_paq.push(["setSiteId","1"]);var e,n=document,t=n.createElement("script"),s=n.getElementsByTagName("script")[0];t.async=!0,t.src=e+"matomo.js",s.parentNode.insertBefore(t,s)}()</script></body></html>